baber/WOPTO huggingface dataset:
Patent AT-E289070-T1 (AT)
Inventor: LARKIN MICHAEL JAMES
IPC: C07K16/12
Filed: 1999-12-06
Granted: 2005-02-15
Abstract: The present application provides a method of detecting Microthrix parvicella comprising reacting M. parvicella with antibodies. The method can further enable the isolation of M. parvicella. Monoclonal antibodies, polyclonal antibody or a cocktail of antibodies maybe employed.
Patent AT-E379853-T1 (AT)
Inventor: CHOI SEUNG-WON
IPC: H01Q23/00
Filed: 1999-12-22
Granted: 2007-12-15
Abstract: This invention relates to a signal processing method and apparatus for an adaptive array antenna. The objective is to suggest an adaptive procedure of computing the suboptimal weight vector for an array antenna system that provides a beampattern having its maximum gain along the direction of the mobile target signal source in a blind signal environment, where the transmitted data are not known (or not to be estimated) at the receiver. It is the ultimate goal of this invention to suggest a practical way of enhancing both the communication quality and communication capacity through the optimal weight vector of the array system that maximizes SINR(Signal to Interference+Noise Ratio). In order to achieve this goal, the method of Lagrange multiplier is modified in such a way that the suboptimal weight vector is produced with the computational load of about O(8N), which has been found to be small enough for the real-time processing of signals in most land mobile communications with the digital signal processor (DSP) off the shelf, where N denotes the number of antenna elements of the array.
Patent AT-E232133-T1 (AT)
Inventor: BRUEGGENDICK HERMANN
IPC: B01D53/56
Filed: 1999-10-22
Granted: 2003-02-15
Abstract: To reduce the quantity of nitrogen oxides resulting from the nitrogen present in fuel, a substoichiometric flame zone is generated and a nitrogen oxide reducing agent introduced into said substoichiometric flame zone. When the oxygen supply is discontinued the reducing agent increases the concentration of radicals which in turn reduce the nitrogen being produced and release molecular oxygen.
Patent DE-02746715-T1 (DE)
Title: Teilnehmernetzwerkempfang und -senden von digitalen paketen
Inventor: PINDER HOWARD G
IPC: H04B1/66
Filed: 2002-06-26
Abstract: Verfahren zum Bereitstellen eines Transportstroms, der eine Gruppe von PID-Strömen aufweist, wobei ein PID-Strom ein Strom von Paketen mit einem gemeinsamen Paketidentifikator (PID), der mit dem Strom von Paketen assoziiert ist, mit einer vorgegebenen maximalen Bitrate ist, wobei das Verfahren in einer Transportstromvorrichtung implementiert ist, die zum Empfangen und Senden von Transportströmen eingerichtet ist, wobei das Verfahren Folgendes aufweist:  Empfangen eines Eingangstransportstroms mit einer Vielzahl von darin enthaltenen PID-Strömen;  Decodieren eines ersten mindestens einen PID-Stroms der Vielzahl von empfangenen PID-Strömen;  statistisches Multiplexen eines zweiten mindestens einen PID-Stroms der Vielzahl von empfangenen PID-Strömen in eine Gruppe von PID-Strömen, wobei die Bitrate der Gruppe von PID-Strömen den vorgegebenen Höchstwert nicht überschreitet;  Codieren eines dritten mindestens einen PID-Stroms der Vielzahl von empfangenen PID-Strömen und  Senden eines vierten mindestens einen PID-Stroms der Vielzahl von empfangenen PID-Strömen von mindestens einem Sender.
Patent DE-491717-T1 (DE)
IPC: A63F9/00
Filed: 1990-07-11
Abstract: A portable, compact, battery-operated light apparatus for use with a compact computer game having a LCD video screen for enhancing the visibility of the LCD screen in use, which light apparatus comprises a body with a battery compartment and having side panels which define an open viewing space and lights provided in the body element to provide for indirect lighting of the viewing space, the light apparatus comprising a portable, compact, battery-powered light apparatus and which includes ridges on the light apparatus which snap in a releasable manner onto the grooves in a compact computer game video system to releasably secure the light apparatus in position over the LCD video screen of the compact game system.
Patent ES-2133256-T1 (ES)
Title: Dispositivo de conversion de una tension alterna en tension continua.
Inventor: BRUNO SERGE
IPC: H02M3/156
Filed: 1998-11-20
Abstract: EL DISPOSITIVO DE CONVERSION DE LAS ALTERNANCIAS POSITIVAS COMPRENDE UNA RESISTENCIA (R1) LIMITACION DE LA CORRIENTE, UN TRANSISTOR (T1) DE CORTE DE LA CORRIENTE CONECTADO EN SERIE CON LA RESISTENCIA (R1), UN CONDENSADOR DE ALMACENAMIENTO DE CORRIENTE (C1) EN SERIE CON EL TRANSISTOR Y EN CUYOS TERMINALES SE TOMA LA TENSION CONTINUA HOMOPOLAR, UN DIVISOR DE TENSION (R2), R3) EN PARALELO A LA RESISTENCIA, AL TRANSISTOR Y AL CONDENSADOR, QUE PROPORCIONA UNA TENSION DE REFERENCIA (VREFM) PROPORCIONAL A LAS ALTERNANCIAS POSITIVAS DE LA TENSION DE ALIMENTACION Y UN MEDIO DE COMPARACION QUE CIERRA EL TRANSISTOR PARA CARGAR EL CONDENSADOR Y QUE ABRE EL TRANSISTOR PARA PERMITIR DESCARGAR EL CONDENSADOR PARA GARANTIZAR LA CONTINUIDAD DE LA TENSION HOMOPOLAR. LA FUNCION DE CMPARACION TAMBIEN ES CUMPLIDA POR EL TRANSISTOR (T1), LO QUE PERMITE SIMPLIFICAR EL CIRCUITO.
Patent CY-1108005-T1 (CY)
Title: Αβερμεκτινη και μονοσακχαριτικα παραγωγα της αβερμεκτινης υποκατασταθεντα στη θεση 4" ή 4', εχοντα παρασιτοκτονες ιδιοτητες
Inventor: PITTERNA THOMAS
IPC: A61K31/70
Filed: 2007-03-20
Abstract: Περιγράφεται μία ένωση τύπου (I) στον οποίο το U είναι -N(R2)OR3 ή –Ν+ (Ο-)=C-(RE)RZ)· το n είναι 0 ή 1· το Χ-Υ είναι -CH=CH- ή -CH2-CH2-· το R1 είναι αλκύλιο με C1-C12, κυκλοαλκύλιο με C3-C8 ή αλκενύλιο με C2-C12· τα R2 και R3 είναι, για παράδειγμα, ανεξάρτητα μεταξύ τους, -Q, -C(=O)-Z-Q ή -CN· τα RZ και RE είναι, ανεξάρτητα μεταξύ τους, -Q, -C(=O)-Z-Q ή -CN· ή τα RZ και RE μαζί είναι μία γέφυρα αλκυλενίου ή αλκενυλενίου με τρία έως επτά μέλη, η οποία είναι μη υποκατασταθείσα ή μονο- έως τρις-υποκατασταθείσα· το Ζ είναι ένας δεσμός, Ο ή -NR4-· το Q είναι Η, αλκύλιο με C1-C12, αλκενύλιο με C2-C12, αλκυνύλιο με C2-C12, κυκλοαλκύλιο με C3-C12, κυκλοαλκενύλιο με C5-C12, αρύλιο ή ετεροκυκλύλιο, τα οποία είναι χωρίς υποκατάσταση ή μονο- έως πεντα-υποκατασταθέντα· το R4 είναι για παράδειγμα Η, αλκύλιο με C1-C8, υδροξυ-αλκύλιο με C1 -C8, κυκλοαλκύλιο με C3-C8, ή αλκενύλιο με C2-C8· ή, αν εφαρμόζεται, ένα ισομερές Ε/Ζ, ένα μίγμα ισομερών Ε/Ζ και/ή ένα ταυτομερές της· μία μέθοδος παρασκευής αυτών των ενώσεων, των ισομερών και ταυτομερών τους και η χρήση αυτών των ενώσεων, των ισομερών και ταυτομερών τους· παρασιτοκτόνες συνθέσεις των οποίων η δραστική ένωση επιλέγεται από αυτές τις ενώσεις και τα ταυτομερή τους· ενδιάμεσα για την παρασκευή των εν λόγω ενώσεων τύπου (I), μέθοδοι για την παρασκευή των ενώσεων τύπου (I) και μία μέθοδος ελέγχου παρασίτων με τη χρήση αυτών των συνθέσεων.
Patent CY-1107135-T1 (CY)
Inventor: RUNGE ERICH
IPC: F16B25/00
Filed: 2008-01-10
Abstract: The screw has a head (2), an essentially cylindrical shaft (4,6,8), a tip and a thread (14) extending over the shaft into the tip area (10) with edges (18,20) on the tip and head sides, whereby the tip edge angle is greater than the head edge angle. The tip edge angle is about the same in the shaft and tip areas but the head edge angle is greater in the tip area than in the shaft area. An independent claim is also included for a wood screw.
Patent CY-1108264-T1 (CY)
Title: Ανθρωπινος ορφανος συζευγμενος σε g πρωτεϊνη υποδοχεας rup3
Inventor: CHEN RUOPING
IPC: C07K14/705
Filed: 2008-08-08
Abstract: Η εφεύρεση αποκαλυπτόμενη σ’ αυτό το έγγραφο διπλώματος ευρεσιτεχνίας αναφέρεται σε διαμεμβράνιους υποδοχείς, πιο συγκεκριμένα σε ενδογενείς, ανθρώπινους ορφανούς συζευγμένους με G πρωτεΐνη υποδοχείς.
Patent CY-1109021-T1 (CY)
Inventor: MARUTIAN SERGEY VASILIEVICH
IPC: C23C2/12
Filed: 2009-04-16
Abstract: The invention refers to applying metal, e.g. aluminum, coatings by plunging into the melt and may be used, for instance, for corrosion protection of rolled and other cast iron and steel products. The result in the method of applying the aluminum coatings on cast iron and steel products comprising product surface preparing and consequent plunging the product into the aluminum melt alloyed with zinc and silicon is reached by jet-abrasive preparing of the product and the aluminum melt is alloyed with zinc, silicon, magnesium and tin, while the temperature of the melt is in the range of 660-680° C.
Patent CY-1109971-T1 (CY)
Title: Μια διαδικασια για την ελαττωση των περιβαλλοντικων ρυπων σ' ενα ελαιο ή ενα λιπος, ενα πτητικο ενεργο ρευστο για την ελαττωση των περιβαλλοντικων ρυπων, ενα συμπληρωμα υγειας, κι ενα προϊον ζωοτροφης
Inventor: BREIVIK HARALD
IPC: A23L5/20
Filed: 2010-03-30
Abstract: Η εφεύρεση αναφέρεται σε μία διαδικασία για την ελάττωση της ποσότητας των περιβαλλοντικών ρύπων σ' ένα μίγμα που περιέχει ένα λίπος ή ένα έλαιο, που είναι βρώσιμο ή για χρήση σε καλλυντικά, το δε λίπος ή έλαιο περιέχει τους περιβαλλοντικούς ρύπους, η οποία διαδικασία συμπεριλαμβάνει τα στάδια της πρόσθεσης ενός πτητικού ενεργού ρευστού στο μίγμα, όπου το πτητικό ενεργό ρευστό περιέχει τουλάχιστον κάποιο από τα εστέρα λιπαρού οξέος, αμίδιο λιπαρού οξέος, ελεύθερο λιπαρό οξύ και υδρογονάνθρακα, και υποβολή του μίγματος με το προστιθέμενο πτητικό ενεργό ρευστό σ' ένα τουλάχιστον στάδιο κατεργασίας με απομάκρυνση, στην οποία μία ποσότητα περιβαλλοντικών ρύπων που έχουν σταλεί από πριν στο λίπος ή το έλαιο, που είναι βρώσιμο ή για χρήση σε καλλυντικά, διαχωρίζεται από το μίγμα μαζί με το πτητικό ενεργό ρευστό. Η παρούσα εφεύρεση επίσης αναφέρεται σ' ένα πτητικό ενεργό ρευστό που ελαττώνει τους περιβαλλοντικούς ρύπους, για χρήση στην ελάττωση μίας ποσότητας περιβαλλοντικών ρύπων που υπάρχουν σ' ένα λίπος ή έλαιο, που είναι βρώσιμο ή για χρήση σε καλλυντικά. Επιπλέον, η παρούσα εφεύρεση αναφέρεται σ' ένα συμπλήρωμα υγείας, ένα φαρμακευτικό προϊόν κι ένα προϊόν ζωοτροφής που παρασκευάζεται σύμφωνα με τη διαδικασία που αναφέρεται παραπάνω.
Patent CY-1111492-T1 (CY)
Title: ΜΙΑ ΜΕΘΟΔΟΣ ΓΙΑ ΤΗΝ ΠΑΡΑΣΚΕΥΗ 10,11-ΔΙΥΔΡΟ-10-ΟΞΟ-5Η-ΔΙΒΕΝΖΟ[b,f]ΑΖΕΠΙΝΟ-5-ΚΑΡΒΟΞΑΜΙΔΙΟΥ
Inventor: LEARMONTH DAVID ALEXANDER
IPC: C07D223/22
Filed: 2011-05-27
Abstract: Μια μέθοδος για την παρασκευή 10,11-διυδρο-10-οξο-5Η-διβενζο/b,f/αζεπινο-5-καρβοξαμίδιoυ (2) από 10,11-διυδρο-10-υδροξυ-5Η-διβενζο/b,f/αζεπινο-5-καρβοξαμίδιο (1) που περιλαμβάνει την οξείδωση του 10,11-διυδρο-10-υδροξυ-5Η-διβενζο/b, f/αζεπινο-5-καρβοξαμίδιου (1) μέσω της αντίδρασης με υπεροξυοξικό οξύ, παρουσία ενός μετάλλου ως καταλύτη σε έναν ουσιαστικά αδρανή διαλύτη.
Patent CY-1112471-T1 (CY)
Inventor: LINZ KLAUS DR
IPC: A61P25/04
Filed: 2012-03-12
Abstract: Use of compounds (I), which exhibit an affinity for the mu -opioid-receptor of at least 100 nM (K i value for human) and an affinity for opioid receptor-like (ORL)-1-receptor, is claimed, where the ratio of the affinities ORL1/mu defined as 1/[K i(ORL1)/K i(mu )] is 1:10 to 30:1, for the production of a medicament and to treat: diabetic neuropathy; narcosis or analgesia during narcosis; pain in patients over 60 years and in patients with increased addictive potential and postoperative pain. An independent claim is included for use of a mu -agonist (II), which is selective as an ORL1/mu defined as 1/[K i(ORL1)/K i(mu )] 1:10, and a ORL1-agonist, which is selective as ORL1/mu defined as 1/[K i(ORL1)/K i(mu )] in a ratio of 30:1 in a mixture, which exhibits the characteristics of the compounds, for the manufacture of medicaments to treat pain. ACTIVITY : Neuroprotective; Analgesic. MECHANISM OF ACTION : Opioid receptor-like-1/mu -agonist.
Patent CY-1113232-T1 (CY)
Inventor: JOHANNESSEN BAARD
IPC: A01P7/04
Filed: 2012-07-27
Abstract: The invention provides a method of treatment of a human subject to combat infestation by multicellular ectoparasites with exoskeletons, in particular head lice, which method comprises topically applying to said subject a first and a second pediculicide, said first pediculicide being a carbamate or organophosphate pediculicide and said second pediculicide being a pyrethroid or pyrethrin pediculicide, characterized in that said second pediculicide is applied between 15 minutes and 12 hours after the application of said first pediculicide.
Patent CY-1113669-T1 (CY)
Title: Υποκατεστημενα βενζιμιδαζολια για την αντιμετωπιση των αστροκυτωματων
Inventor: STUART DARRIN
IPC: A61K31/4439
Filed: 2012-12-18
Abstract: Η παρούσα εφεύρεση σχετίζεται με τη χρήση ΠΑΡΑΓΩΓΩΝ ΒΕΝΖΙΜΙΔΑΖΟΛΙΩΝ για την παρασκευή ενός φαρμάκου για την αντιμετώπιση των αστροκυτωμάτων.
Patent CY-1115889-T1 (CY)
Title: Μεθοδοι παρασκευης του ζοφενοπριλικου ασβεστιου
Inventor: GORE VINAYAK G
IPC: A61K31/401
Filed: 2014-11-20
Abstract: Η παρούσα εφεύρεση αναφέρεται στη μορφή Α ζοφενοπριλικού ασβεστίου ουσιαστικά απαλλαγμένη άλλων μορφών ζοφενοπριλικού ασβεστίου και στο ζοφενοπριλικό ασβέστιο το οποίο έχει χημική καθαρότητα μεγαλύτερη από 98,5%. Η παρούσα εφεύρεση αναφέρεται επίσης σε μεθόδους παρασκευής ενός τέτοιου ζοφενοπριλικού ασβεστίου. Αναφέρεται περαιτέρω σε συνθέσεις που περιλαμβάνουν τέτοιο ζοφενοπριλικό ασβέστιο. Το ζοφενοπριλικό ασβέστιο, άλας ασβεστίου της (4S)-1-[(2S)-3-βενζοϋλθειο-2-μεθυλπροπιονυλ]-4-(φαινυλθειο)-L-προλίνης, έχει την ακόλουθη δομή:
Patent CY-1121113-T1 (CY)
Inventor: VAN BREE JOHANNES GERNARDUS MATHIAS MARIE
IPC: C12N9/24
Filed: 2018-07-10
Abstract: The invention provides methods of treating Pompe's disease using human acid alpha glucosidase. A preferred treatment regime comprises administering greater than 10mg/kg body weight per week to a patient.
Patent CY-1121401-T1 (CY)
Title: Ενωση φαινυλο-τετραϋδροϊσοκινολινης υποκατεστημενη με ετεροαρυλ
Inventor: KURODA SHOICHI
IPC: C07D401/14
Filed: 2019-01-30
Abstract: Η παρούσα εφεύρεση παρέχει μια ένωση που αντιπροσωπεύεται από τον ακόλουθο τύπο [1] ή ένα φαρμακευτικώς αποδεκτό άλας αυτής που έχει ένα εξαιρετικό ανασταλτικό αποτέλεσμα ΝΗΕ3: όπου το Α παριστά μία δομή που αντιπροσωπεύεται από τον ακόλουθο τύπο [2]: όπου τα R11 και R12 αντιπροσωπεύουν το καθένα ένα άτομο αλογόνου ή τα παρόμοια, το R2 αντιπροσωπεύει C 1-6 αλκύλιο ή τα παρόμοια, ο δακτύλιος Ε αντιπροσωπεύει τριαζόλη, τετραζόλη, πυριμιδίνη ή τα παρόμοια, τα R31 και R32 παριστάνουν έκαστο άτομο υδρογόνου, C 1-6 αλκυλ, C 1-6 αλκοξυ ή τα παρόμοια και το W αντιπροσωπεύει έναν απλό δεσμό, τον τύπο -ΝΗ-, τον τύπο -Ο- ή τον τύπο -CONH-, και το Υ αντιπροσωπεύει ένα άτομο υδρογόνου ή μια δομή που αντιπροσωπεύεται από τον ακόλουθο τύπο [3 ']:
Patent HR-P20090419-T1 (HR)
Title: Novel indeno [2,1a]indenes and isoindol [2,1-a]indoles
Inventor: JASTI VENKATESWARLU
IPC: C07D513/04
Filed: 2009-07-29
Abstract: The present invention provides indeno[2,1a]indene and isoindolo[2,1-a]indole derivatives of the Formula I, its salts and its stereoisomers, wherein X, R<SUB>1</SUB>, R<SUB>2</SUB>, R<SUB>3</SUB>, R<SUB>4</SUB>, R<SUB>6</SUB>, R<SUB>7</SUB>, R<SUB>8</SUB>, R<SUB>9</SUB>, R<SUB>11</SUB>, R<SUB>12</SUB>, R<SUB>13 </SUB>and R<SUB>14 </SUB>are as described in the specification. The invention also provides a method to prepare the compound of formula I, pharmaceutical composition containing such compounds, and method to manufacture a medicament. These compounds are useful in the treatment of various CNS disorders, hematological disorders, eating disorders, diseases associated with pain, respiratory diseases, genito-urological disorders, cardio vascular diseases and cancer.
Patent HR-P20090516-T1 (HR)
Inventor: DZIENNIK DAVID BRIAN
IPC: A61K31/4365
Filed: 2009-09-25
Abstract: Formulacija koja sadrži terapijski djelotvornu količinu spoja formule Ipakirana u blister-pakiranje nepropusno za zrak i vlagu, napunjeno inertnim plinom. Patent sadrži još 13 patentnih zahtjeva.
Patent HR-P20100435-T1 (HR)
Inventor: KERBER FRIEDRICH
IPC: D21H19/68
Filed: 2010-08-04
Abstract: Postupak za proizvodnju prevlake koja se ne kliže, na nosaču (1) koji je u obliku tanke ploče ili se može odmotati sa valjka, za poboljšanje svojstava nosača (1) kod obrađivanja povezanih sa trenjem, za kasnije korake obrađivanja, kao što je na primjer rezanje, prešanje ili postupci sklapanja, gdje se pokrivni sloj (3) sastoji od laka koji se nanosi na barem jednu od dvije površine (5) nosača (1), pri čemu se lak otiskuje na samo na parcijalne plohe površine (5) nosača (1), a prije nanošenja pokrivnog sloja (3), na površini (5) nosača (1) primjenjuje se postupak otiskivanja jednobojnog ili višebojnog sloja, naznačen time, da se pokrivni sloj (3) nanosi u obliku rešetke. Patent sadrži još 3 patentna zahtjeva.
Patent HR-P20110572-T1 (HR)
Title: Preparation of 3-[(1r,2r)-3-(dimethylamino)-1ethyl-2-methylpropyl] phenol
Inventor: HELL WOLFGANG
IPC: C07C215/54
Filed: 2011-08-02
Abstract: The present invention relates to an improved process for the preparation of 3-[(1R,2R)-3-(dimethylamino)-1-ethyl-2-methylpropyl]phenol monohydrochloride.
Patent HR-P20120564-T1 (HR)
Title: Reading device for a packaging sign
Inventor: ROBERT JANSEN
IPC: G01N21/55
Filed: 2012-07-10
Abstract: The packing has an outer covering, which forms a substrate, on which a signet is applied externally. The signet has signal area (18), which is arranged to the contrast area (14) and to the safety area (16) in a fixed allocated area. The signet has a comparatively high reflectivity or low reflectivity, depending on whether the subsurface of the safety area is metallic reflecting (total reflecting) or diffused reflecting. An independent claim is also included for the readout unit for a signet of a packing.
Patent SI-1224177-T1 (SI)
Title: Process for preparing oxazolines from tetrahydrofurans
Inventor: BUSSE JULIETTE KHARSA
IPC: C07D217/26
Filed: 2000-10-19
Abstract: Methods for the preparation of chemical intermediates in the synthesis of HIV-protease inhibitors related to and including nelfinavir mesylate are disclosed. The method of this invention comprises converting tetrohydran derivatives into oxazolines to provide key reaction intermediates for the preparation of nelfinavir. Also disclosed is a method for the preparation of a chiral amino alcohol from an epoxy-tetrahydrofuran.
Patent SI-1289569-T1 (SI)
Title: Diagnosing colic type in an infant
Inventor: BUCKLEY MARY MARGARET
IPC: A61K49/00
Filed: 2000-06-09
Abstract: A method for diagnosing colic type in an infant exhibiting one or more symptoms characteristic of unspecified colic comprises the steps of optionally measuring in said infant at least one parameter indicative of unspecified colic; orally administering a liquid formulation of a  beta -D-galactosidase enzyme separately, simultaneously with or sequentially to a lactose-containing feed; and determining at selected intervals of time any alteration in said infant of colic-type symptoms. An improvement in said symptoms of at least 50 % or greater is indicative of lactose-based intolerance. Where the enzyme formulation fails to alleviate the symptoms of unspecified colic, the infant is then placed on a diet of low allergen feed. An improvement in said symptoms of 50 % or more is indicative of allergen-based colic requiring maintenance on a low allergen-based diet. A failure to respond to such a low allergen-based diet is indicative of a need of further investigation, because the symptoms may be due to low-level infection or a metabolic error.
Patent SI-1626974-T1 (SI)
Title: Substituted benzopyrans as selective estrogen receptor-beta agonists
Inventor: DURST GREGORY LEE
IPC: A61K31/00
Filed: 2004-04-08
Abstract: The present invention relates to substituted benzopyran derivatives, stereoisomers, and pharmaceutical acceptable salts thereof useful as Estrogen Receptor beta agonists for treating Estrogen Receptor beta mediated diseases such as benign prostatic hyperplasia.
Patent SI-1744789-T1 (SI)
Title: X-ray and/or uv activatable particles, their preparation and their therapeutic or diagnostic uses
Inventor: LEVY LAURENT
IPC: A61K9/00
Filed: 2005-05-09
Abstract: The present invention relates to novel activatable particles which can be used in the health sector. The invention more particularly relates to composite particles which can generate free radicals or heat when excited by X rays, and to the uses thereof in health, particularly human. The inventive particles comprise an inorganic-based, and optionally organic-based, nucleus and can be activated in vivo, in order to label or alter cells, tissues or organs. The invention also relates to methods for the production of said particles, and to pharmaceutical or diagnostic compositions containing same.
Patent SI-1896274-T1 (SI)
Title: Railway vehicle wheel with elastic rubber suspension
Inventor: MURAWA FRANZ
IPC: B60B17/00
Filed: 2006-06-30
Abstract: A rubber-sprung wheel for rail vehicles includes a wheel tire which is connected to a wheel rim by a rubber insert that is formed by two flat rings that are arranged so as to be essentially vertical in relation to a wheel axle. The two flat rings are held, under considerable axial prestress, between an inner circumferential middle web of the wheel tire and two outer flanges of the wheel rim. At least one of the flanges is seated on the wheel rim with an interference fit that is designed as a conical press fit, such that a cone of the flange in a stress-free state has a lesser conicity than does a cone of the wheel rim, and in a pressed-on state rests on an entire surface against the cone of the wheel rim, at an even surface pressure across an entire width of the interference fit.
Patent SI-1924117-T1 (SI)
Title: Method and simulator for effecting registrative and manipulative accesses to a mobile terminal
Inventor: KOUADJO LARISSE NANA
IPC: H04W88/08
Filed: 2006-05-19
Abstract: A simulator (1) is positioned in close proximity to a mobile terminal (7) to be identified. A measuring system (11) determines parameters relevant to the data transmission of base stations (6) in close proximity to the mobile terminal, and transmits the parameters to the simulator. The simulator operates as a new base station (2) based on the parameters but having another location area code. The mobile terminal recognizes the simulator as a new base station and logs onto the simulator using its identification parameters. The mobile terminal is redirected to a GSM mobile radio network. An independent claim is also included for a simulator.
Patent SI-1989249-T1 (SI)
Title: A composite material
Inventor: ALDERSON ANDREW
IPC: C08J5/00
Filed: 2007-05-24
Abstract: A composite material comprises a layer of fibres conjoined to a matrix, where one of the matrix and fibres comprises a first component which exhibits auxetic behaviour for loading along a first direction, and the other of the matrix and fibres comprises a second component which exhibits non-auxetic behaviour for loading along the first direction.
Patent SI-2492355-T1 (SI)
Title: Tissue protective erythropoietin receptor (nepor) and methods of use
Inventor: JACKSON DAVID B
IPC: G01N33/00
Filed: 2008-11-28
Abstract: There is disclosed a molecular composition(s) of a novel tissue protective erythropoietin (EPO) binding receptor protein complex, termed NEPOR. Presence of NEPOR components on a tumour allows EPO to impinge on the survival of associated cells thereby enhancing tumour progression and negatively effecting patient survival. There is disclosed that presence of NEPOR represents a prognostic biomarker for poorer patient outcome. Thus, the method disclosed is for stratifying patients having a tumour as suitable (i.e. NEPOR not present) or non-suitable (i.e., NEPOR present) for EPO treatment, comprising: (a) isolating a tissue sample from an individual who is receiving or is a candidate for receiving erythropoietin, (b) determining the level of expression of the NEPOR gene(s) (mRNA) and/or the presence of the NEPOR gene product (protein) from the isolated tissue, and (c) correlating the presence of an NEPOR gene expression product or the presence of NEPOR protein to a physiological response to the treatment with erythropoietin. Furthermore, by disclosing the molecular compositions of NEPOR species, there are disclosed methods for rationally identifying/designing NEPOR modulating therapeutics. Thus, the present disclosure provides methods for treating neurological insults such as stroke (via enhancement of NEPOR activity) and cancer (via down-regulation of cyto-protective signaling from NEPOR).